Company: JUNS
Filing Date: 2025-11-26
Form Type: S-1
Source: 0001493152-25-025204
Chunk: 193

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-26
Form: S-1
Chunk 193
---
 the base salary shall be adjusted to be 105% the original
base salary.

On December 17, 2024, the parties agreed that
the Company would pay to Titan a monthly fee in the amount of $20,000 (amounting to an aggregate annual fee of $240,000) for the 2025
calendar year. In addition, Titan is eligible for cash bonuses and additional equity compensation, at the Company’s discretion.

| 110 |

Elements of Compensation

Our NEOs were provided with the following primary
elements of compensation in 2024 and 2023:

Base Salary

Christer Rosén and Marshall Hayward received
a fixed base salary in an amount determined by the Board based on a number of factors, including:

| ● | The nature, responsibilities and duties of the officer’s position;                                                           |
| ● | The officer’s expertise, demonstrated leadership ability and prior performance;                                              |
| ● | The officer’s salary history and total compensation, including annual cash bonuses and long-term incentive compensation; and |
| ● | The competitiveness of the market for the officer’s services.                                                                |

See “—2024 Summary Compensation Table.”

Stock Option Grants

On January 1, 2023, the Company granted non-qualified
stock option to purchase 562,500 of common stock to Saleem Elmasri, CPA, as Chief Financial Officer, at an exercise price of $1.33 per
share.

On September 29, 2023, the Company granted non-qualified
stock options to purchase 710,344 of common stock to Christer Rosén at an exercise price of $1.33 per share.

On September 29, 2023, the Company granted non-qualified
stock options to purchase 556,673 of common stock to Marshall Hayward at an exercise price of $1.33 per share.

On September 29, 2023, the Company granted non-qualified
stock options to purchase 81,600 of common stock to Saleem Elmasri, CPA at an exercise price of $1.33 per share.

On December 18, 2023, the Company granted non-qualified
stock options to purchase 88,909 of common stock to Christer Rosén at an exercise price of $1.33 per share.

On December 18, 2023, the Company granted non-qualified
stock options to purchase 69,675 of common stock to Marshall Hayward at an exercise price of $1.33 per share